Aeterna Zentaris Liabilities 2024

Aeterna Zentaris Aktienanalyse

What does Aeterna Zentaris do?

Aeterna Zentaris Inc. is a Canadian company that has been operating in the pharmaceutical industry since 1991. The company is headquartered in Quebec City, Canada and focuses on the development and commercialization of drugs for the treatment of cancer and hormonal disorders. The company started as a small biotech company called "Aeterna Laboratories" that focused on the research of growth hormones and hormonal disorders. In the late 90s, it merged with a German company called "Zentaris GmbH" that specialized in medical diagnostics and chemicals, creating Aeterna Zentaris AG, which was later renamed Aeterna Zentaris Inc. The company has acquired several companies and expanded its portfolio of drugs and treatment options. Aeterna Zentaris is a biopharmaceutical company engaged in preclinical and clinical development of therapeutics. The company's main strategy is to develop and promote innovative and differentiating drug candidates. It works closely with leading academic institutions, researchers, and other companies to advance the development of its products. Aeterna Zentaris has a diversified portfolio of drug candidates in various stages of clinical development. It has two main divisions: cancer treatment and hormonal disorders. The company focuses on developing cancer therapeutics for various types of cancers and also on the treatment of hormonal disorders, including diabetes, growth problems, hormonally related cancers, and menopause. Some of the company's important products include Macrilen, which is used for diagnosing growth hormone deficiency, Zoptrex, which is intended for the treatment of endometrial cancer, and Perifosine, a drug candidate for advanced colorectal cancer. Aeterna Zentaris has established itself as a leading biotech company in the field of cancer and hormone therapy. It has a diverse portfolio of drug candidates in different stages of clinical development. The company collaborates with researchers, medical institutions, and other companies to develop innovative and differentiating drug candidates. Aeterna Zentaris ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Aeterna Zentaris's Liabilities

Aeterna Zentaris's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Aeterna Zentaris's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Aeterna Zentaris's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Aeterna Zentaris's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Aeterna Zentaris’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Aeterna Zentaris stock

What is the level of liabilities of Aeterna Zentaris this year?

Aeterna Zentaris has a debt balance of 18.82 M USD this year.

What were the liabilities of Aeterna Zentaris compared to the previous year?

The liabilities of Aeterna Zentaris have increased by -7.29% dropped compared to the previous year.

What are the consequences of high debt for investors of Aeterna Zentaris?

High liabilities can pose a risk for investors of Aeterna Zentaris, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Aeterna Zentaris?

Low liabilities mean that Aeterna Zentaris has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Aeterna Zentaris affect the company?

An increase in liabilities of Aeterna Zentaris can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Aeterna Zentaris affect the company?

A decrease in the liabilities of Aeterna Zentaris can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Aeterna Zentaris?

Some factors that can influence the liabilities of Aeterna Zentaris include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Aeterna Zentaris so important for investors?

The liabilities of Aeterna Zentaris are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Aeterna Zentaris take to modify the liabilities?

To change its liabilities, Aeterna Zentaris can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Aeterna Zentaris pay?

Over the past 12 months, Aeterna Zentaris paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aeterna Zentaris is expected to pay a dividend of 0 USD.

What is the dividend yield of Aeterna Zentaris?

The current dividend yield of Aeterna Zentaris is .

When does Aeterna Zentaris pay dividends?

Aeterna Zentaris pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aeterna Zentaris?

Aeterna Zentaris paid dividends every year for the past 0 years.

What is the dividend of Aeterna Zentaris?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aeterna Zentaris located?

Aeterna Zentaris is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aeterna Zentaris kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aeterna Zentaris from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Aeterna Zentaris pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Aeterna Zentaris in the year 2023?

In the year 2023, Aeterna Zentaris distributed 0 USD as dividends.

In which currency does Aeterna Zentaris pay out the dividend?

The dividends of Aeterna Zentaris are distributed in USD.